New molecule could reverse neurodegeneration in Parkinson’s

News

Author: Simge Eva DoganPublished: 11 October 2018

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

molecule

Researchers at a university in Spain have discovered a new molecule which they claim can block and reverse neurodegeneration in Parkinson’s.

The molecule – named SynuClean-D – is able to reduce alpha-synuclein aggregations which cause degeneration.

The study – published in science journal ‘PNAS’ – explains how researchers at the Universitat Autònoma de Barcelona, Spain, tested over 14,000 molecules before discovering SynuClean-D.

They then tested the molecule on a Caenorhabditis worm – one of the most commonly used animals when researching neurodegenerative diseases – finding that it boosted its mobility and protected it from neural degeneration.

Salvador Ventura, the study coordinator, said: “Everything seems to indicate that the molecule we identified, the SynuClean-D, may provide therapeutic applications for the treatment of neurodegenerative diseases such as Parkinson’s in the future.”

To read more on this topic click here.

For more information on the latest Parkinson’s research please visit Parkinson’s Europe website.

Go Back

Share this story

Comments


Related articles


Tim Hague Parkinson's Vision 2020

Interviews

Young onset Parkinson’s: “How I look is not how I feel”

The first in our series profiling Parkinson's Vision 2020 speakers

READ MORE
An action shot of Jense Greve playing table tennis.

Global update

“We want the feeling of togetherness to take centre stage”

An exciting table tennis event for Parkinson’s disease community

READ MORE
Boston Scientific

sponsored article

Advances

Better results and fewer side effects with personalised DBS Therapy

Ongoing studies: better results in DBS with innovative technology

READ MORE